Publisher: Wiley-Blackwell

Related content
Volume 6, Number 2, March 2005

< previous issue | all issues | next issue >

Favourites:Add to Favourites

Free Content Ethnic differences in stage of presentation of adults newly diagnosed with HIV-1 infection in south London
pp. 59-65(7)
Authors: Boyd, AE; Murad, S; O'Shea, S; de Ruiter, A; Watson, C; Easterbrook, PJ

Favourites:Add to Favourites
Favourites:Add to Favourites

Free Content Patient characteristics and costs associated with dyslipidaemia and related conditions in HIV-infected patients: a retrospective cohort study
pp. 79-90(12)
Authors: Richter, A; Pladevall, M; Manjunath, R; Lafata, JE; Xi, H; Simpkins, J; Brar, I; Markowitz, N; Iloeje, UH; Irish, W

Favourites:Add to Favourites

Free Content Enhanced glucagon-like peptide-1 (GLP-1) response to oral glucose in glucose-intolerant HIV-infected patients on antiretroviral therapy
pp. 91-98(8)
Authors: Andersen, O; Haugaard, SB; Holst, JJ; Deacon, CF; Iversen, J; Andersen, UB; Nielsen, JO; Madsbad, S

Favourites:Add to Favourites

Free Content Comparison of gastrointestinal tolerability and patient preference for treatment with the 625 mg and 250 mg nelfinavir tablet formulations
pp. 107-113(7)
Authors: Johnson, M; Nieto-Cisneros, L; Horban, A; Arasteh, K; Gonzalez-Garcia, J; Artigas, JG; Clotet, B; Danise, A; Landman, R; Proll, S; Snowden, W; Foreman, R; Smith, P

Favourites:Add to Favourites

Free Content Effects of HIV disease on lipid, glucose and insulin levels: results from a large antiretroviral-naïve cohort
pp. 114-121(8)
Authors: El-Sadr, WM; Mullin, CM; Carr, A; Gibert, C; Rappoport, C; Visnegarwala, F; Grunfeld, C; Raghavan, SS

Favourites:Add to Favourites

Free Content The 48-week efficacy of once-daily saquinavir/ritonavir in patients with undetectable viral load after 3 years of antiretroviral therapy
pp. 122-128(7)
Authors: Cardiello, P; Srasuebkul, P; Hassink, E; Mahanontharit, A; Samor, T; Ruxrungtham, K; Lange, J; Cooper, D; Phanuphak, P

Favourites:Add to Favourites

Free Content Factors associated with virological response in HIV-infected patients failing antiretroviral therapy: a prospective cohort study
pp. 129-134(6)
Authors: Fournier, S; Chaffaut, C; Maillard, A; Loze, B; Lascoux, C; Gérard, L; Timsit, J; David, F; Bergmann, J-F; Oksenhendler, E; Sereni, D; Chevret, S; Molina, J-M

Favourites:Add to Favourites

Free Content Mitochondrial DNA depletion in liver tissue of patients infected with hepatitis C virus: contributing effect of HIV infection?
pp. 135-139(5)
Authors: Bäuerle, J; Laguno, M; Mauss, S; Mallolas, J; Murillas, J; Miquel, R; Schmutz, G; Setzer, B; Gatell, JM; Walker, UA

Favourites:Add to Favourites

Free Content The prevalence and risk of immune restoration disease in HIV-infected patients treated with highly active antiretroviral therapy
pp. 140-143(4)
Authors: Jevtović, DJ; Salemović, D; Ranin, J; Pešić, I; Žerjav, S; Djurković-Djaković, O

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more